Skip to content

Renal Denervation in Patients with Uncontrolled Hypertension SYMPLICITY® HTN-2

Renal Denervation in Patients with Uncontrolled Hypertension SYMPLICITY® HTN-2 - Renal Denervation

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35153
Enrollment
10
Registered
2010-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensie Chronic kidney disease (or) chronic renal disease high blood pressure Hypertension

Interventions

Sponsors

Ardian, Inc.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Individual has a systolic blood pressure higher than 160 mmHg (higher than 150 mmHg for type 2 diabetics).;2. Individual is adhering to a stable drug regimen including 3 or more antihypertensive medications (with no changes for a minimum of 2 weeks prior to enrollment) that is expected to be maintained for at least 6 months.;3. Individual is *18 and * 85 years of age.

Exclusion criteria

Exclusion criteria: 1. Individual has anatomically abnormal renal artery (this is defined in detail in the study protocol on page 13).;2. Individual has an estimated glomerular filtration rate (eGFR) of

Design outcomes

Primary

MeasureTime frame
Effect of kidney denervation on blood pressure from baseline to 6 months post-denervation. Expected outcome: - Substantial decrease in blood pressure

Secondary

MeasureTime frame
- Safety (this is extensively described in the study protocol page 16) o Acute Procedural Safety * to be compared against other common interventions (renal stenting, angioplasty, etc.) o 6 Month Safety *compared between groups at 6 months postrandomization eGFR drop of >25% o Composite Cardiovascular Endpoint * compared between groups at 6 months post-randomization -Blood pressure reduction: o Incidence of achieving target SBP (SBP 10 mmHg reduction in SBP at 6 months post-randomization. o Incidence of high blood pressure actions and low blood pressure actions through 6 months post-randomization. o Change in Office Diastolic Blood Pressure (DBP) from baseline to 6 months post-randomization o Change in 24 hour ambulatory blood pressure from baseline to 6 months post-randomization. o Changes in SBP and DBP from baseline to 12, 18, 24, 30 & 36 months after renal denervation. - Left Ventricular (LV) Function: among patients with LV hypertrophy at baseline, change in LV mass at 6 months following renal denervation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)